Carregant...
Bortezomib Reduces Preexisting Antibodies to Recombinant Immunotoxins in Mice()
Recombinant immunotoxin (RIT) therapy is limited in patients by neutralizing antibody responses. Ninety percent of patients with normal immune systems make neutralizing antibodies after one cycle of RIT, preventing repeated dosing. Furthermore, some patients have preexisting antibodies from environm...
Guardat en:
| Publicat a: | J Immunol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4323725/ https://ncbi.nlm.nih.gov/pubmed/25560410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1402324 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|